Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × fostamatinib × Clear all

NCT02611063 2023-03-17

Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms